Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to Marc Peter Bonaca

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Bonaca, Marc

Item TypeName
Concept Risk Factors
Academic Article Comparative Efficacy of Endovascular Revascularization Versus Supervised Exercise Training in Patients With Intermittent Claudication: Meta-Analysis of Randomized Controlled Trials.
Academic Article Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I.
Academic Article DECLARE-TIMI 58: Participants' baseline characteristics.
Academic Article Efficacy and safety of vorapaxar as approved for clinical use in the United States.
Academic Article Efficacy and safety of vorapaxar in patients with prior ischemic stroke.
Academic Article Vorapaxar in patients with peripheral artery disease: results from TRA2{degrees}P-TIMI 50.
Academic Article American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38).
Academic Article Antiplatelet Therapy for Secondary Prevention After Acute Myocardial Infarction.
Academic Article Diagnosis and management of acute aortic syndromes: dissection, intramural hematoma, and penetrating aortic ulcer.
Academic Article Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54.
Academic Article Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
Academic Article Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial.
Academic Article Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial.
Academic Article Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22.
Academic Article Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes status.
Academic Article The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 Trial.
Academic Article Prognostic performance of a high-sensitivity assay for cardiac troponin I after non-ST elevation acute coronary syndrome: Analysis from MERLIN-TIMI 36.
Academic Article Antithrombotic Therapy in Patients With Peripheral Artery Disease.
Academic Article Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis.
Academic Article Recurrent Aortic Dissection: Observations From the International Registry of Aortic Dissection.
Academic Article Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
Academic Article Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
Academic Article Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
Academic Article Polyvascular disease and risk: When two is not better than one.
Academic Article Appropriate secondary prevention and clinical outcomes after acute myocardial infarction according to atherothrombotic risk stratification: The FAST-MI 2010 registry.
Academic Article Prevalence and Outcomes of Polyvascular (Coronary, Peripheral, or Cerebrovascular) Disease in Patients With Diabetes Mellitus (From the SAVOR-TIMI 53 Trial).
Academic Article Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study.
Academic Article Atherothrombotic risk stratification after acute myocardial infarction: The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French Registry of Acute ST Elevation or non-ST Elevation Myocardial Infarction registries.
Academic Article Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial.
Academic Article Prognostic role of GDF-15 across the spectrum of clinical risk in patients with NSTE-ACS.
Academic Article Vorapaxar for secondary prevention in the elderly with peripheral artery disease: Insights from the TRA 2?P-TIMI 50 trial.
Academic Article Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.
Academic Article Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.
Academic Article Outcome associated with prescription of cardiac rehabilitation according to predicted risk after acute myocardial infarction: Insights from the FAST-MI registries.
Academic Article Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54.
Academic Article Microvascular Disease, Peripheral Artery Disease, and Amputation.
Academic Article Tackling Elevated Risk in PAD: Focus on Antithrombotic and Lipid Therapy for PAD.
Academic Article Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2?P-TIMI 50 trial.
Academic Article The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism.
Academic Article No Significant Relationship Between Ticagrelor and Sleep Apnea in Large, Randomized, Blinded Trials.
Academic Article Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial.
Academic Article Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial.
Academic Article Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines.
Academic Article Contemporary Review of Antithrombotic Therapy in Peripheral Artery Disease.
Academic Article Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic Disease.
Academic Article Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic Disease.
Academic Article New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?
Academic Article Healthcare resource utilization and costs of major atherothrombotic vascular events among patients with peripheral artery disease after revascularization.
Academic Article Incidence of Major Atherothrombotic Vascular Events among Patients with Peripheral Artery Disease after Revascularization.
Academic Article Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial.
Academic Article Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2?P-TIMI 50.
Academic Article Contemporary Medical Management of Peripheral Artery Disease.
Academic Article Impact of Polyvascular Disease and Diabetes on?Limb and Cardiovascular Risk in Peripheral Artery Disease.
Academic Article Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD.
Academic Article Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2?P-TIMI 50 trial.
Academic Article The prognostic implications of cardiac troponin in Type A aortic dissection and the challenge of understanding therapeutic consequences.
Academic Article A polygenic risk score predicts atrial fibrillation in cardiovascular disease.
Academic Article Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis.
Academic Article Tradeoffs in Approach to PAD?Revascularization: Shared Decision Making in the Spotlight.
Academic Article Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54.
Academic Article Guideline-Directed Medical Therapy in?PAD: Time to Step on the Gas.
Academic Article Sex differences in guideline-directed medical therapy in 2021-22 among patients with peripheral artery disease.
Academic Article Trends of Concomitant Diabetes and Peripheral Artery Disease and Lower Extremity Amputation in US Medicare Patients, 2007 to 2019.
Academic Article Disparities in Diagnosis, Treatment, and?Outcomes of Peripheral Artery?Disease: JACC Scientific Statement.

Search Criteria
  • Risk Factors

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)